Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature.

Richter S, Cormican MG, Pfaller MA, Lee CK, Gingrich R, Rinaldi MG, Sutton DA.

J Clin Microbiol. 1999 Apr;37(4):1154-60. Review.

2.
3.

Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone.

Cormican MG, Jones RN.

Antimicrob Agents Chemother. 1997 Jan;41(1):204-11.

4.

Standardization of antifungal susceptibility testing.

Cormican MG, Pfaller MA.

J Antimicrob Chemother. 1996 Oct;38(4):561-78. Review.

5.

A Mycobacterium malmoense-specific DNA probe from the 16S/23S rRNA intergenic spacer region.

Glennon M, Cormican MG, Ni Riain U, Heginbothom M, Gannon F, Smith T.

Mol Cell Probes. 1996 Oct;10(5):337-45.

PMID:
8910888
6.

Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae.

Jones RN, Cormican MG, Wanger A.

Diagn Microbiol Infect Dis. 1996 Aug;25(4):201-4.

PMID:
8937845
7.
8.

Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.

Cormican MG, Marshall SA, Jones RN.

J Clin Microbiol. 1996 Aug;34(8):1880-4.

9.

Phenotypic detection of mec A-positive staphylococcal blood stream isolates: high accuracy of simple disk diffusion tests.

Cormican MG, Wilke WW, Barrett MS, Pfaller MA, Jones RN.

Diagn Microbiol Infect Dis. 1996 Jul;25(3):107-12.

PMID:
8902404
10.

DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata.

Cormican MG, Hollis RJ, Pfaller MA.

Diagn Microbiol Infect Dis. 1996 Jun;25(2):83-7.

PMID:
8882894
11.

In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates.

Cormican MG, Jones RN.

J Antimicrob Chemother. 1996 Apr;37(4):847-9. No abstract available.

12.

Reevaluation of contemporary laboratory methods for detection of antimicrobial resistance among enterococci.

Cormican MG, Biedenbach D, Jones RN.

Clin Microbiol Infect. 1996 Mar;1(3):190-194.

13.
14.

Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis.

Cormican MG, Erwin ME, Marshall SA, Jones RN.

Diagn Microbiol Infect Dis. 1996 Mar;24(3):155-60.

PMID:
8724401
15.

False resistance to metronidazole by E-test among anaerobic bacteria investigations of contributing test conditions and medium quality.

Cormican MG, Erwin ME, Jones RN.

Diagn Microbiol Infect Dis. 1996 Feb;24(2):117-9. No abstract available.

PMID:
9147908
16.

Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.

Cormican MG, Johnson DM, Jones RN.

Diagn Microbiol Infect Dis. 1996 Jan;24(1):59-60. No abstract available.

PMID:
8988766
18.
19.

Epidemiology of candidiasis.

Cormican MG, Pfaller MA.

Compr Ther. 1995 Nov;21(11):653-7. Review. No abstract available.

PMID:
8697737
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk